- Home
- / Cellect Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cellect Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| ILS | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating expense total | 28.8M | 21.5M | 1.6M | 6.0M | 9.2M | 9.3M | 9.4M | 16.2M |
| Depreciation and amortization | 452.0K | 809.0K | 104.0K | 104.0K | 104.0K | 122.0K | 100.0K | 100.0K |
| EBITDA | (28.8M) | (21.5M) | (1.6M) | (6.0M) | (9.2M) | (9.3M) | (9.4M) | (16.2M) |
| EBIT | (29.2M) | (22.3M) | (1.7M) | (6.1M) | (9.3M) | (9.4M) | (9.5M) | (16.3M) |
| Interest income | 9.2M | 7.0M | 96.0K | 695.0K | 559.0K | 482.0K | ||
| Interest expense | 20.0K | 1.5M | 47.0K | 1.4M | 714.0K | |||
| Pre tax profit | (20.1M) | (16.8M) | (2.1M) | (21.5M) | (9.4M) | (8.7M) | (9.0M) | (15.8M) |
| Net Income | (20.1M) | (16.8M) | (2.1M) | (21.5M) | (9.4M) | (8.7M) | (9.0M) | (15.8M) |